Should you buy ResMed (RMD)?
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
- Wide Moat Compounder Quality→Stable
- Perfect Earnings Beat Streak↓Deteriorating
- Technical Downtrend Accumulation Window↓Deteriorating
- +1 more pillar — see the Why tab for full reasoning
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Wide Moat Compounder Quality
Trip ifReturn on equity falls below 18% for 2 consecutive quarters, signaling the competitive moat is weakening under margin pressure.
- P2Perfect Earnings Beat Streak
Trip ifEPS surprise falls below 0% in at least 2 of the next 4 quarters, ending the sustained beat pattern.
- P3Technical Downtrend Accumulation Window
Trip ifPrice drops below $170, more than 12% below the current $192.74, confirming the downtrend is deepening rather than stabilizing.
- P4Analyst Upside Valuation GapTripped
Trip ifAnalyst consensus price target falls below $200, indicating analysts are cutting their fair value estimates by more than 20% from current levels.
How the engine reached this verdict
TrendMatrix's engine output for ResMed Inc. (RMD) is STRONG_BUY_WAIT with medium conviction, score 6.2/10 at $195.80. The engine flags WAIT: the structural case holds but the entry-asymmetry math improves at lower prices.
The engine's suggested entry zone is $191.10, currently 2.5% above entry. Target $223.86, stop $175.59, asymmetric R:R 1.81. The WAIT designation reflects entry-discipline framing — chasing into the current zone compresses asymmetry, which is why the engine separates WAIT from NOW. The engine's sizing output: 1.7% of portfolio at this asymmetry level (high-conviction tier).
On the bull side: Strong earnings beat streak (4/4); High-quality business; Positive insider activity. On the bear side: Negative momentum; Below 200-MA, MA slope -4.6%/30d (confirmed downtrend). Active engine warnings: V9 Gate Failed: MOMENTUM:1.6<4.5, V9 Gate Failed: DEATH_CROSS:HARD_BLOCK.
BUY_NOW requires momentum at 1.6 vs threshold 4.5 to clear (1.6 → ≥4.5) OR price pulling back to the entry zone of $191.10 with asymmetry crossing 2.5. The verdict flips to HOLD if overall score deteriorates by ~0.7 from sentiment or technical drift.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates RMD — 10-dimension breakdown →
Bull case
- ▸Strong earnings beat streak (4/4)
- ▸High-quality business
- ▸Positive insider activity
Bear case
- ▸Negative momentum
- ▸Below 200-MA, MA slope -4.6%/30d (confirmed downtrend)